课题项目：EphA2受体通过抑制Ras通路下游MAPK、AKT信号分子以靶，省部级；靶向治疗及逆转K-Ras基因突变相关性耐药胰腺癌的实验研究，厅局级；突变KRAS驱动胰腺癌的DNA甲基化谱特征的研究，厅局级。论文发表：Ribosomal DNA Copy Number Is Associated With P53 Status and Levels of Heavy Metals in Gastrectomy Specimens From Gastric Cancer Patients，Environment International，2020/05/18，IF:7.943；AGTR1 Is Overexpressed in Neuroendocrine Neoplasms, Regulates Secretion and May Potentially Serve as a Target for Molecular Imaging and Therapy，Cancers，2020/10/27，IF:6.126；Letter to the editor: BET inhibitors might target innate inflammatory and profibrotic signaling networks in COPD.，Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L648-L649.，2017/01/01，IF:4.281；IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1)，Cancer Chemother Pharmacol，2018/01/01，IF:2.808；Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer，J Pharm Pharmacol，2019/01/01，IF:2.309。